WeVote

Bill

Bill

HB 5710

AN ACT REQUIRING NEWBORN SCREENING FOR DUCHENNE MUSCULAR DYSTROPHY.

2025 Regular Session Introduced by Aimee Berger-Girvalo and 6 co-sponsors

Connecticut requires hospitals to screen all newborns for Duchenne muscular dystrophy to enable early medical intervention and family planning.

REF. TO JOINT COMM. ON Public Health
0
WeVote Research Nonpartisan
Bill Summary · HB 5710

Legislative bill overview

HB 5710 mandates that Connecticut include Duchenne muscular dystrophy (DMD) screening in its newborn screening program. This genetic disorder causes progressive muscle weakness and typically manifests in early childhood. The bill requires the state to identify affected infants shortly after birth through standardized screening protocols.

Why is this important

Early detection of DMD allows families to begin medical interventions—including physical therapy, medications, and monitoring—that can significantly improve quality of life and slow disease progression. Newborns identified through screening can receive counseling, genetic testing confirmation, and access to emerging treatments like gene therapy before symptoms appear. Currently, DMD is often diagnosed only after symptoms become apparent, potentially delaying critical care by months or years.

Potential points of contention

  • Program costs and infrastructure: Adding DMD to screening programs requires laboratory capacity, equipment, and staff training; funding mechanisms are unclear
  • False positive rates and anxiety: DMD screening may produce false positives requiring follow-up testing, potentially causing parental distress before confirmation
  • Limited treatment options at diagnosis: While early detection enables monitoring and some interventions, definitive cures remain limited, raising questions about the practical benefit of screening versus the emotional burden of early diagnosis

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.